Stockreport

Ocugen Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Ocugen, Inc.  (OCGN) 
PDF MALVERN, Pa., Oct. 16, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene t [Read more]